-
Je něco špatně v tomto záznamu ?
Patient with inoperable pheochromocytoma
D. Brancíková, Z. Mechl, Z. Adam, E. Jandáková, Z. Pavlovský, V. Válek, Z. Andrašina,
Jazyk angličtina Země Kanada
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
Open Access Digital Library
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2005
PubMed
26089731
DOI
10.3747/co.22.2324
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Malignant pheochromocytoma is a tumour with a very low incidence that occurs sporadically or in the presence of multiple endocrine neoplasia. We present the case of a woman with a sporadic occurrence of pheochromocytoma diagnosed in the phase of multiple dissemination in the abdominal cavity and overexpressing adrenaline, noradrenaline, and dopamine. Local transarterial chemoembolization and systemic treatment with lanreotide resulted in a very good response, a decrease in the production of catecholamines for 12 months and a partial decrease for another 8 months, with stabilization of disease determined by imaging. Systemic treatment with tegafur resulted in disease stabilization lasting 50 months, after which the drug was discontinued because of adverse effects. Maintenance therapy with lanreotide continues, and no disease progression has been observed for 4 months. The treatment algorithm for such patients is multidisciplinary and must always take into account the current scope of the disease, intercurrence, and the general condition of the patient.
Department of Radiology University Hospital Brno Brno Czech Republic
Institute of Pathology University Hospital Brno Brno Czech Republic
Internal Hematological and Oncological Clinic University Hospital Brno Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023676
- 003
- CZ-PrNML
- 005
- 20210121105934.0
- 007
- ta
- 008
- 150709s2015 xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3747/co.22.2324 $2 doi
- 035 __
- $a (PubMed)26089731
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Brancíková, D $u Medical Faculty, Masaryk University, Brno, Czech Republic; ; Internal Hematological and Oncological Clinic, University Hospital Brno, Brno, Czech Republic;
- 245 10
- $a Patient with inoperable pheochromocytoma / $c D. Brancíková, Z. Mechl, Z. Adam, E. Jandáková, Z. Pavlovský, V. Válek, Z. Andrašina,
- 520 9_
- $a Malignant pheochromocytoma is a tumour with a very low incidence that occurs sporadically or in the presence of multiple endocrine neoplasia. We present the case of a woman with a sporadic occurrence of pheochromocytoma diagnosed in the phase of multiple dissemination in the abdominal cavity and overexpressing adrenaline, noradrenaline, and dopamine. Local transarterial chemoembolization and systemic treatment with lanreotide resulted in a very good response, a decrease in the production of catecholamines for 12 months and a partial decrease for another 8 months, with stabilization of disease determined by imaging. Systemic treatment with tegafur resulted in disease stabilization lasting 50 months, after which the drug was discontinued because of adverse effects. Maintenance therapy with lanreotide continues, and no disease progression has been observed for 4 months. The treatment algorithm for such patients is multidisciplinary and must always take into account the current scope of the disease, intercurrence, and the general condition of the patient.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mechl, Z $u Medical Faculty, Masaryk University, Brno, Czech Republic; ; Internal Hematological and Oncological Clinic, University Hospital Brno, Brno, Czech Republic;
- 700 1_
- $a Adam, Zdeněk $u Medical Faculty, Masaryk University, Brno, Czech Republic; ; Internal Hematological and Oncological Clinic, University Hospital Brno, Brno, Czech Republic; $7 jn19981000018
- 700 1_
- $a Jandáková, E $u Medical Faculty, Masaryk University, Brno, Czech Republic; ; Institute of Pathology, University Hospital Brno, Brno, Czech Republic;
- 700 1_
- $a Pavlovský, Z $u Medical Faculty, Masaryk University, Brno, Czech Republic; ; Department of Radiology, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Válek, Vlastimil, $d 1960- $7 nlk20010098982 $u Medical Faculty, Masaryk University, Brno, Czech Republic; ; Department of Radiology, University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Andrašina, Z $u Medical Faculty, Masaryk University, Brno, Czech Republic; ; Department of Radiology, University Hospital Brno, Brno, Czech Republic. $7 gn_A_00006333
- 773 0_
- $w MED00165427 $t Current oncology (Toronto, Ont.) $x 1198-0052 $g Roč. 22, č. 3 (2015), s. e216-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26089731 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20210121105933 $b ABA008
- 999 __
- $a ind $b bmc $g 1084008 $s 906669
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 22 $c 3 $d e216-9 $i 1198-0052 $m Current oncology $n Curr. oncol. $x MED00165427
- LZP __
- $a Pubmed-20150709